Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3G1Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,863
Award facts
- Contract value 100% obligated
- $11,862.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,862.59 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen's parent company's Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2031. The IDC serves as the primary mechanism for delivering a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related medical commodities to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F3G1Q?
SPE2DR26F3G1Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F3G1Q worth?
The government has obligated $11,863 on SPE2DR26F3G1Q.
Is contract SPE2DR26F3G1Q an order under another contract?
Yes. SPE2DR26F3G1Q is a delivery order under SPE2DR25D3001, an indefinite delivery contract.
Was contract SPE2DR26F3G1Q competed?
The extent of competition for SPE2DR26F3G1Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award